Home
Resources
Publications
Oxygenated UW Solution Decreases ATP Decay and Improves Survival After Transplantation of DCD Liver Grafts

Oxygenated UW Solution Decreases ATP Decay and Improves Survival After Transplantation of DCD Liver Grafts

Paulo N Martins, Timothy A Berendsen, Heidi Yeh, Bote G Bruinsma, Maria-Louisa Izamis, Sanna Op den Dries, Andrew R Gillooly, Robert Porte, Martin L Yarmush, Korkut Uygun, James F Markmann

Transplantation. 2019 Feb;103(2):363-370.

PMID: 30422952

Abstract:

Background:
Donation after circulatory death (DCD) liver grafts are known to be predisposed to primary nonfunction and ischemic cholangiopathy. Many DCD grafts are discarded because of older donor age or long warm ischemia times. Thus, it is critical to improve the quality of DCD liver grafts. Here, we have tested whether an enriched oxygen carrier added to the preservation solution can prolong graft survival and reduce biliary damage.
Methods:
We assessed the adenosine triphosphate (ATP) content decay of mouse liver grafts after cold ischemia, warm ischemia, and combined warm+cold ischemia. In addition, we used a rat model of liver transplantation to compare survival of DCD grafts preserved in high-oxygen solution (preoxygenated perfluorocarbon [PFC] + University of Wisconsin [UW] solution) versus lower oxygen solution (preoxygenated UW solution).
Results:
Adenosine triphosphate levels under UW preservation fall to less than 10% after 30 minutes of warm ischemia. Preoxygenated UW solution with PFC reached a significantly higher PaO2. After 45 minutes of warm ischemia in oxygenated UW + PFC solution, grafts showed 63% higher levels of ATP (P = 0.011). In addition, this was associated with better preservation of morphology when compared to grafts stored in standard UW solution. Animals that received DCD grafts preserved in higher oxygenation solution showed improved survival: 4 out of 6 animals survived long-term whereas all control group animals died within 24 hours.
Conclusions:
The additional oxygen provided by PFC during static cold preservation of DCD livers can better sustain ATP levels, and thereby reduce the severity of ischemic tissue damage. PFC-based preservation solution extends the tolerance to warm ischemia, and may reduce the rate of ischemic cholangiopathy.

Chemicals Related in the Paper:

Catalog Number	Product Name	CAS Number	Price
AP1020719554	9-Hydroxyrisperidone-D4 solution	1020719-55-4	Price
AP1126623208	Gabapentin-D10 solution	1126623-20-8	Price
AP1184980424	Phenazepam-D4 solution	1184980-42-4	Price
AP1189656641	4′-Hydroxydiclofenac-13C6 solution	1189656-64-1	Price
AP1189980480	Pregabalin-13C3 solution	1189980-48-0	Price
AP1190003634	Amobarbital-D5 solution	1190003-63-4	Price
AP1218911160	Carisoprodol-D7 solution	1218911-16-0	Price
AP136765441	Morphine-D3-3-β-D-glucuronide solution	136765-44-1	Price
AP136765510	Temazepam-d5 solution	136765-51-0	Price
AP145225032	Oxymorphone-D3 solution	145225-03-2	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: